April W Armstrong (A Armstrong, A W Armstrong, April Armstrong)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 89

Top Venues

Dermatology and therapy

The Journal of rheumatology

Journal of the European Academy of Dermatology and Venereology : JEADV

The Journal of dermatological treatment

Keck School of Medicine of the University of Southern California

Lewis and Clark College (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Keck School of Medicine of the University of Southern California

United States

Professor of Dermatology :: Dermatology

Keck School of Medicine of the University of Southern California

United States

Associate Dean for Clinical Research :: Keck School of Medicine

Keck School of Medicine of the University of Southern California

United States

Director, Clinical Trials and Outcomes Research :: Dermatology

Keck School of Medicine of the University of Southern California

United States

Director, Clinical Research :: Southern California Clinical and Translational Science Institute (SC CTSI)

Keck School of Medicine of the University of Southern California

United States

Vice Chair of Clinical Research :: Dermatology

Keck School of Medicine of the University of Southern California

United States

Director, Psoriasis Program :: Dermatology

University of Colorado Hospital

United States

Director, Clinical Trials and Outcomes Research :: Dermatology

University of Colorado

United States

Director, Psoriasis Program :: Dermatology

University of Colorado Hospital

United States

Tenured Associate Professor of Dermatology :: Deratology

University of Colorado Hospital

United States

Vice Chair of Clinical Research :: Dermatology

University of California Davis

United States

Vice Chair of Clinical Research :: Dermatology

University of California Davis

United States

Director, Dermatology Clinical Research Unit :: Dermatology

University of California Davis

United States

Director, Psoriasis Clinic :: Dermatology

University of California Davis

United States

Associate Professor :: Dermatology

University of California Davis

United States

Director, Teledermatology Program :: Dermatology

Education History

Lewis and Clark College

United States

BSC :: Biochemistry and Communication

Publications

Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy 14 (8) (2024)
April W Armstrong, Sang Hee Park, Vardhaman Patel, Pierre Nicolas, Wei-Jhih Wang, Matthew J Colombo, Viktor Chirikov
Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis. Dermatology and therapy 14 (7) (2024)
April W Armstrong, Sayeli Jayade, Sanika Rege, Namita Joshi, Vardhaman Patel, Samaneh Kalirai, Daniel Wolin, Kimberly Boyle, Dipen Patel, Lauren Seigel
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey. Dermatology and therapy 14 (2) (2024)
M Elaine Husni, Shashank Cheemalavagu, April W Armstrong, Lihi Eder
Insights and Innovations: A Review of the GRAPPA 2023 Trainee Symposium. The Journal of rheumatology (2024)
April W Armstrong, Sang Hee Park, Vardhaman Patel, Pierre Nicolas, Wei-Jhih Wang, Matthew J Colombo, Viktor Chirikov
Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis. Dermatology and therapy (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy (2024)
Margaret Y Huang, Paige Kingston, Hannah Peterson, Danielle Yee, Kathryn Lee, Edwin Korouri, Rosario Agüero, April W Armstrong
Depression screening for psoriasis in the United States: A population-based study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV 38 (5) (2024)
April W Armstrong, Sang Hee Park, Vardhaman Patel, Pierre Nicolas, Wei-Jhih Wang, Matthew J Colombo, Viktor Chirikov
Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis. Dermatology and therapy 14 (7) (2024)
April W Armstrong, Sayeli Jayade, Sanika Rege, Namita Joshi, Vardhaman Patel, Samaneh Kalirai, Daniel Wolin, Kimberly Boyle, Dipen Patel, Lauren Seigel
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey. Dermatology and therapy 14 (2) (2024)
Margaret Y Huang, Paige Kingston, Hannah Peterson, Danielle Yee, Kathryn Lee, Edwin Korouri, Rosario Agüero, April W Armstrong
Depression screening for psoriasis in the United States: A population-based study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy 14 (8) (2024)
April W Armstrong, Sayeli Jayade, Sanika Rege, Namita Joshi, Vardhaman Patel, Samaneh Kalirai, Daniel Wolin, Kimberly Boyle, Dipen Patel, Lauren Seigel
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey. Dermatology and therapy 14 (2) (2024)
April W Armstrong, Sayeli Jayade, Sanika Rege, Namita Joshi, Vardhaman Patel, Samaneh Kalirai, Daniel Wolin, Kimberly Boyle, Dipen Patel, Lauren Seigel
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey. Dermatology and therapy (2024)
Dafna D Gladman, Oliver M FitzGerald, April W Armstrong, Niti Goel, Alice B Gottlieb
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 Annual Meeting. The Journal of rheumatology (2024)
Wilson Liao, April W Armstrong, Kristina Callis Duffin
GRAPPA Debate: Targeted Small Molecules Versus Biologics as First-Line Systemic Therapy After Conventional Therapy for Moderate-to-Severe Psoriasis. The Journal of rheumatology (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy 14 (8) (2024)
April W Armstrong, Sang Hee Park, Vardhaman Patel, Pierre Nicolas, Wei-Jhih Wang, Matthew J Colombo, Viktor Chirikov
Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis. Dermatology and therapy 14 (7) (2024)
Gretchen D Ball, Danielle K Yee, Arianna J Zhang, Lourdes Maria Perez-Chada, Vibeke Strand, Joseph Frank Merola, April W Armstrong, Alice B Gottlieb
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting. The Journal of rheumatology (2024)
April W Armstrong, Sang Hee Park, Vardhaman Patel, Pierre Nicolas, Wei-Jhih Wang, Matthew J Colombo, Viktor Chirikov
Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis. Dermatology and therapy 14 (7) (2024)
Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Bruce E Strober, Hervé Bachelez, Jeffrey Crowley, Boni E Elewski, Melinda J Gooderham, Martin Alan Menter, Robert Strohal, Michael M Chen, Tianshuang Wu, Tianyu Zhan, Huzefa Photowala, April W Armstrong
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). Journal of the European Academy of Dermatology and Venereology : JEADV 38 (5) (2024)
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, Tan P Pham, Stacie Hudgens, Kenneth B Gordon, Joe Zhuo, Brandon Becker, Yichen Zhong, Renata M Kisa, Subhashis Banerjee, Kim A Papp
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and therapy (2024)
Margaret Y Huang, Paige Kingston, Hannah Peterson, Danielle Yee, Kathryn Lee, Edwin Korouri, Rosario Agüero, April W Armstrong
Depression screening for psoriasis in the United States: A population-based study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Robin Kikuchi, Paige Kingston, Audrey Hao, Kaviyon Sadrolashrafi, Rebecca K Yamamoto, Hannah Tolson, Sara N Bilimoria, Lily Guo, Danielle Yee, Maria T Ochoa, April W Armstrong
Shared decision-making in psoriasis care: Evaluation of how patients' perception of clinicians' delivery of care changes by age and sex. PloS one 19 (5) (2024)
Arianna J Zhang, Lourdes Maria Perez-Chada, Vibeke Strand, April W Armstrong, Alice B Gottlieb, Joseph Frank Merola
GRAPPA 2023 Annual Meeting Report: Hot Topic Session on Measurement of Musculoskeletal Symptoms in Psoriatic Disease. The Journal of rheumatology (2024)
Robin Kikuchi, Paige Kingston, Audrey Hao, Kaviyon Sadrolashrafi, Rebecca K Yamamoto, Hannah Tolson, Sara N Bilimoria, Lily Guo, Danielle Yee, Maria T Ochoa, April W Armstrong
Shared decision-making in psoriasis care: Evaluation of how patients' perception of clinicians' delivery of care changes by age and sex. PloS one 19 (5) (2024)
April W Armstrong, Sayeli Jayade, Sanika Rege, Namita Joshi, Vardhaman Patel, Samaneh Kalirai, Daniel Wolin, Kimberly Boyle, Dipen Patel, Lauren Seigel
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey. Dermatology and therapy (2024)
April W Armstrong, Sang Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David Davidson, Viktor V Chirikov
Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Dermatology and therapy (2023)
April W Armstrong, Manish Patel, Chao Li, Vishvas Garg, Monika Rao Mandava, Jashin J Wu
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States. The Journal of dermatological treatment 34 (1) (2023)
Rosario Agüero, Michael J Woodbury, Kathryn Lee, Hanna J Johnsson, Joseph Frank Merola, April W Armstrong
Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics? The Journal of rheumatology (2023)
Andreas Pinter, Linda F Stein Gold, Adam Reich, Lawrence J Green, Morten Praestegaard, Johan Selmer, April W Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra Elkjaer Stallknecht, Paw Trebbien, Matthias Augustin
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Fazira R Kasiem, Daisuke Yamada, Josefina Marin, Marijn Vis, William Tillett, Samuel T Hwang, Enrique Roberto Soriano, Oliver M FitzGerald, April W Armstrong
GRAPPA 2021 Pilot Grant Award Reports. The Journal of rheumatology (2023)
Paige Kingston, Samiya Khan, Justin Chan, Sarah P Pourali, April W Armstrong, Vincent DeLeo, Brandon L Adler
Trends in Patch-Test Positivity to Methylchloroisothiazolinone and Methylisothiazolinone Based on Regulatory Status: A Systematic Review. Dermatitis : contact, atopic, occupational, drug (2023)
Paige Kingston, Margaret Y Huang, Kathryn Lee, Hannah Peterson, Edwin Korouri, Rosario Agüero, Danielle Yee, April W Armstrong
The impact of race on mental health outcomes among patients with hidradenitis suppurativa: a population-based study in the United States. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
April W Armstrong, Sang Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David Davidson, Viktor V Chirikov
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Dermatology and therapy (2023)
Melissa P Zundell, Michael J Woodbury, Kathryn Lee, Lourdes Maria Perez-Chada, April W Armstrong, Vibeke Strand, Joseph Frank Merola, Alice B Gottlieb
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting. The Journal of rheumatology (2023)
Kathryn Lee, Danielle K Yee, Hannah Peterson, Margaret Y Huang, Paige Kingston, Rosario Agüero, Edwin Korouri, April W Armstrong
Readability, quality, and comprehensiveness of online health resources for skin cancer in skin of color. International journal of dermatology (2023)
April W Armstrong, Richard Bruce Warren, Yichen Zhong, Joe Zhuo, Allie Cichewicz, Ananth Kadambi, Daniela Rezende Junqueira, Tracy Westley, Renata Kisa, Carolin Daamen, Matthias Augustin
Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis. Dermatology and therapy (2023)
Nicole Maynard, April W Armstrong
The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness. Current dermatology reports 12 (2) (2023)
Margaret Y Huang, Hannah Peterson, Danielle Yee, Kathryn Lee, Edwin Korouri, Paige Kingston, Rosario Agüero, Khristina Lung, April W Armstrong
Atopic Dermatitis and the Risk of Actinic Keratosis Development: A Population-Based Study. Dermatitis : contact, atopic, occupational, drug (2023)
Beverly Cheok Kuan Ng, Deepak R Jadon, Adewale O Adebajo, Gizem Ayan, Kristina Callis Duffin, Vinod Chandran, Laura C Coates, Maria Antonietta D'Agostino, Kurt de Vlam, Atul A Deodhar, Lihi Eder, Amit Garg, Dafna D Gladman, Niti Goel, Alice B Gottlieb, M Elaine Husni, Arnon M Katz, Arthur Kavanaugh, Ennio Lubrano, Phillip J Mease, Joseph Frank Merola, Peter Nash, Philip S Helliwell, Stephen R Pennington, Lourdes Maria Perez-Chada, Fabian Proft, Cheryl F Rosen, Laura Savage, Cláudia Goldenstein-Schainberg, Stefan Siebert, Enrique Roberto Soriano, Ingrid Steinkoenig, William Tillett, April W Armstrong, Oliver M FitzGerald
Proceedings of the GRAPPA 2022 Executive Retreat. The Journal of rheumatology (2023)
Alice B Gottlieb, April W Armstrong, Oliver M FitzGerald, Dafna D Gladman
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting. The Journal of rheumatology (2023)
M Elaine Husni, Raminderjit Kaur, April W Armstrong, Lihi Eder
GRAPPA 2022 Trainee Symposium: A Summary of Oral and Poster Presentations. The Journal of rheumatology (2023)
Jonathan Ian Silverberg, April W Armstrong, Andrew Blauvelt, Kristian Reich
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids. American journal of clinical dermatology (2023)
April W Armstrong, Manish Patel, Chao Li, Vishvas Garg, Monika Rao Mandava, Jashin J Wu
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States. The Journal of dermatological treatment (2023)
Jonathan Ian Silverberg, April W Armstrong, Andrew Blauvelt, Kristian Reich
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids. American journal of clinical dermatology (2023)
Carmel Stober, Iain B McInnes, Soumya Raychaudhuri, Phillip J Mease, Stephen R Pennington, Jose U Scher, Vinod Chandran, April W Armstrong, Maarten P T de Wit, Alberto Cauli, Deepak R Jadon, Thorvardur Jon Love, Philip S Helliwell, Denis O'Sullivan, Leonieke J J van Mens, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting. The Journal of rheumatology 49 (6 Suppl 1) (2022)
A C Gustafson, Joel M Gelfand, J Davies, A E Lieberman, J B Mason, April W Armstrong, Philip S Helliwell, Nehal N Mehta, John S Barbieri, Rinad S Beidas
Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic Disease. Journal of psoriasis and psoriatic arthritis 7 (4) (2022)
Deepak Mukesh Wieshwaykumar Balak, Lourdes Maria Perez-Chada, Lisa N Guo, Carol Mita, April W Armstrong, Stacie J Bell, George C Gondo, Wilson Liao, Joseph Frank Merola
Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis Foundation. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
A C Gustafson, Joel M Gelfand, J Davies, A E Lieberman, J B Mason, April W Armstrong, Philip S Helliwell, Nehal N Mehta, John S Barbieri, Rinad S Beidas
Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic Disease. Journal of psoriasis and psoriatic arthritis 7 (4) (2022)
Jenna E Yousif, Joseph Frank Merola, Lourdes Maria Perez-Chada, Caterina Zagona-Prizio, April W Armstrong, Philip S Helliwell, Sangyoon Shin, Alice B Gottlieb
Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting. The Journal of rheumatology 49 (6 Suppl 1) (2022)
George C Gondo, Megan Mosca, Julie J Hong, Emanual Maverakis, Joseph Frank Merola, April W Armstrong, Tina Bhutani, Stacie J Bell, Wilson Liao
Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis. Dermatology and therapy 12 (8) (2022)
April W Armstrong, Rasika M Reddy, Keith Colaco, Pamela A Diaz, Raminderjit Kaur, David Simon, Matteo Vecellio, M Elaine Husni
2021 GRAPPA Trainee Symposium: A Summary of Oral and Poster Presentations. The Journal of rheumatology (2022)
Andreas Pinter, Linda F Stein Gold, Adam Reich, Lawrence J Green, Morten Praestegaard, Johan Selmer, April W Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra Elkjaer Stallknecht, Paw Trebbien, Matthias Augustin
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Danielle K Yee, April W Armstrong
Re-Classification of Psoriasis Severity: Perspectives and Controversy. Journal of psoriasis and psoriatic arthritis 7 (1) (2022)
Sabrina Khan, Danielle Yee, Samiya Khan, Manan Mehta, Caterina Zagona-Prizio, Nicole Maynard, Rasika Reddy, April W Armstrong
Biologics to breast milk: A cross-sectional study of popular eczema treatment content on TikTok. Pediatric dermatology 39 (6) (2022)
April W Armstrong, Rasika M Reddy, Oliver M FitzGerald, Kristina Callis Duffin, Philip S Helliwell, Phillip J Mease, Arthur Kavanaugh, Joseph Frank Merola, William Tillett, Maarten de Wit
2021 GRAPPA Meet the Experts Session: A Summary of Presentations. The Journal of rheumatology 49 (6 Suppl 1) (2022)
April W Armstrong, Julie Hahn-Pedersen, Chris Bartlett, Julie M Glanville, Jacob Pontoppidan Thyssen
Economic Burden of Chronic Hand Eczema: A Review. American journal of clinical dermatology 23 (3) (2022)
Caterina Zagona-Prizio, Nicole Maynard, Sabrina Khan, Danielle K Yee, Rasika Reddy, Manan D Mehta, Samiya Khan, April W Armstrong
Perceptions of biologic treatment among hidradenitis suppurativa patients on social media: an analysis of content, engagement, and sentiment. International journal of dermatology (2022)
Christopher T Ritchlin, April W Armstrong, Hanna J Johnsson, Michelle L M Mulder
GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations. The Journal of rheumatology (2021)
Robin Waxman, Carmel Stober, Deepak R Jadon, Ana Maria Orbai, Vinod Chandran, Philip S Helliwell, Stephen R Pennington, Maarten de Wit, Denis O'Sullivan, Phillip J Mease, April W Armstrong, Kristina Callis Duffin, Philip S Helliwell, Leonieke J J van Mens, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting. The Journal of rheumatology. Supplement 96 (2021)
Kristian Reich, Kenneth B Gordon, Bruce E Strober, April W Armstrong, Megan Miller, Y K Shen, Y You, C Han, Y W Yang, Peter Foley, Christopher Ernest Maitland Griffiths
Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2. The British journal of dermatology (2021)
Carmel Stober, Deepak R Jadon, April W Armstrong, Vinod Chandran, Maarten de Wit, Philip S Helliwell, Phillip J Mease, Philip S Helliwell, Denis O'Sullivan, Stephen R Pennington, Thorvardur Jon Love, Alberto Cauli, Leonieke J J van Mens, Robin Waxman, Jose U Scher, Richard B Warren, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. The Journal of rheumatology (2021)
Sarah P Pourali, Yasmin Gutierrez, Alison H Kohn, Jeffrey R Rajkumar, Madison E Jones, April W Armstrong
Chronic spontaneous urticaria in the United States: patient characteristics and treatment patterns. International journal of dermatology (2021)
Gil Yosipovitch, Marjolein de Bruin-Weller, April W Armstrong, Jashin J Wu, Pedro Herranz Pinto, Diamant Thaҫi, Dimittri Delevry, Gaëlle Bégo-Le Bagousse, Raymond Zhang, Brad Shumel, Ana Beatris Rossi, Jingdong Chao
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy 11 (6) (2021)
Patricia Commiskey, April W Armstrong, Tumaini R Coker, Earl Ray Dorsey, John C Fortney, Kenneth J Gaines, Brittany M Gibbons, Huong Q Nguyen, Daisy Radha Singla, Eva Maria Szigethy, Elizabeth A Krupinski
A Blueprint for the Conduct of Large, Multisite Trials in Telemedicine. Journal of medical Internet research 23 (9) (2021)
Lourdes Maria Perez-Chada, Alison H Kohn, Alice B Gottlieb, April W Armstrong, Lihi Eder, Phillip J Mease, Philip S Helliwell, Vibeke Strand, Joseph Frank Merola
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting. The Journal of rheumatology. Supplement 97 (2021)
Lourdes Maria Perez-Chada, Alison H Kohn, Alice B Gottlieb, April W Armstrong, Lihi Eder, Phillip J Mease, Philip S Helliwell, Vibeke Strand, Joseph Frank Merola
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting. The Journal of rheumatology (2021)
Kristian Reich, April W Armstrong, Peter Foley, Michael Song, Megan Miller, Y K Shen, Yin You, Chenglong Han, Kenneth B Gordon
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study. American journal of clinical dermatology 21 (6) (2021)
April W Armstrong, S Gerdes
Calcipotriol/betamethasone dipropionate foam demonstrates comparable efficacy to clinical trial data in the real world, improves patient satisfaction and is cost-effective. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Yasmin Gutierrez, Sarah P Pourali, Alison H Kohn, Madison E Jones, Jeffrey R Rajkumar, April W Armstrong
Topical opioid use in dermatologic disease: A systematic review. Dermatologic therapy 34 (6) (2021)
Yasmin Gutierrez, Sarah P Pourali, Indira Singh, April W Armstrong
Pemphigus and bullous pemphigoid in the United States: a 21-year analysis of patient characteristics, treatment patterns, and comorbidities. The Journal of dermatological treatment (2021)
Yasmin Gutierrez, Andrea J Borba, Dominic J Grisafe, April W Armstrong
Childhood atopic dermatitis: outpatient visit trends, demographics, and topical agents in the United States, 1995-2015. International journal of dermatology 60 (10) (2021)
Sarah P Pourali, Yasmin Gutierrez, Madison E Jones, Jeffrey R Rajkumar, Alison H Kohn, April W Armstrong
Are we contributing to the opioid epidemic? A systematic review on systemic opioid use in dermatology. International journal of dermatology (2021)
Christopher T Ritchlin, April W Armstrong, Hanna J Johnsson, Michelle L M Mulder
GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations. The Journal of rheumatology. Supplement 97 (2021)
Andrew Blauvelt, April W Armstrong, Richard G Langley, Kurt Gebauer, Diamant Thaҫi, Jerry Bagel, Lyn C Guenther, Carle F Paul, Bruce Randazzo, Susan Flavin, Ming-Chun Hsu, Yin You, Kristian Reich
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study. The Journal of dermatological treatment (2021)
Lourdes Maria Perez-Chada, Joseph Frank Merola, April W Armstrong, Alice B Gottlieb
Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting. The Journal of rheumatology. Supplement 96 (2021)
Carmel Stober, Deepak R Jadon, April W Armstrong, Vinod Chandran, Maarten de Wit, Philip S Helliwell, Phillip J Mease, Philip S Helliwell, Denis O'Sullivan, Stephen R Pennington, Thorvardur Jon Love, Alberto Cauli, Leonieke J J van Mens, Robin Waxman, Jose U Scher, Richard B Warren, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. The Journal of rheumatology. Supplement 97 (2021)
A A Kassardjian, V S Chat, L Archuleta, J Hekmatjah, T J Sierro, C Read, A Y Chen, I Singh, April W Armstrong
Words matter: a randomized controlled study evaluating the impact of decision-framing on treatment preferences in adults with psoriasis and psoriatic arthritis. The British journal of dermatology 184 (5) (2021)
Vipawee S Chat, Joshua Hekmatjah, Tiffany J Sierro, Ari A Kassardjian, Charlotte Read, April W Armstrong
Language proficiency and biologics access: a population study of psoriasis patients in the United States. The Journal of dermatological treatment (2020)
Kaitlyn M Yim, Rebecca M Yim, Sara Gaspard, Jamie MacDougall, April W Armstrong
Strategies to maximize clinical efficiency while maintaining patient safety during the COVID-19 pandemic: an interview-based study from private practice dermatologists. The Journal of dermatological treatment (2020)
April W Armstrong, Andrew Blauvelt, J J Crowley, K B Gordon, G G Krueger, J G Krueger, J M Sobell, Bruce E Strober, B Srivastava, A Menter
Defining drug-free remission of skin disease in patients with plaque psoriasis. The British journal of dermatology 182 (6) (2020)
Indira Singh, Vipawee S Chat, Angeline Uy, Andrea Borba, Alice Y Chen, April W Armstrong
Who sees you matters: a population study examining topical corticosteroid prescribing patterns between primary care providers and dermatologists for atopic dermatitis. The Journal of dermatological treatment (2020)
P H Deng, C J Wang, April W Armstrong
An association between hidradenitis suppurativa and HIV. The British journal of dermatology 182 (2) (2019)
Kristian Reich, Peter Foley, Chenglong Han, Sean McElligott, Erik Muser, Nan Li, April W Armstrong
Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab. The Journal of dermatological treatment 31 (6) (2019)
R G Langley, April W Armstrong, M G Lebwohl, Andrew Blauvelt, S Hsu, S Tyring, S Rastogi, R Pillai, R Israel
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials. The British journal of dermatology 180 (2) (2018)

April W Armstrong.css-eqlu8i{font-size:small;padding-left:4px;} (A Armstrong, A W Armstrong, April Armstrong)

Publication Activity (10 Years)

Top Topics

Top Venues

April W Armstrong (A Armstrong, A W Armstrong, April Armstrong)